Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

UMOD Gene Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (send policy image).

Test Overview & Methodology

The UMOD (Uromodulin) gene Genetic Test screens for pathogenic variants responsible for autosomal dominant tubulointerstitial kidney disease, often presenting as glomerulocystic kidney disease with hyperuricemia and isosthenuria. It provides a definitive molecular diagnosis, guiding nephrology management and family cascade testing. This comprehensive analysis employs Next-Generation Sequencing (NGS) with confirmatory Sanger sequencing to ensure maximal accuracy across the full coding region and intron boundaries.

Feature Our UMOD NGS Test Closest Alternative (Single‑Gene Sanger)
CoverageFull coding region ±10 bp intron boundaries; copy number variant detectionLimited to selected exons or known hotspot mutations
MethodNext‑Generation Sequencing (NGS) with confirmatory SangerSanger sequencing only
Turnaround3–4 weeks4–6 weeks
Clinical Sensitivity>99.9% for point mutations/indels~95% for targeted regions
UAE Home CollectionYes (DHA-licensed phlebotomy, 8 AM‑11 PM)Often not available

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics specialist, I emphasise that UMOD genetic findings must always be combined with renal imaging, serum uric acid levels, and urine osmolality for accurate clinical interpretation. This molecular result is one component of a comprehensive diagnostic workup and should never be used in isolation to determine treatment pathways."

— Lina Osama Zaki Quteineh, DHA Registration ID: 9294403

⚠ Medication Advisory

Do not discontinue prescribed medication (e.g., urate‑lowering therapy, antihypertensives) without consulting your treating physician. Genetic findings must be integrated by your nephrologist or primary care provider.

Exclusion Criteria & Emergency Red Flags

  • This test is not intended for standalone prenatal or pre‑implantation genetic diagnosis without dedicated genetic counselling.
  • Do not use this test in an acute setting to rule out kidney injury; seek immediate emergency care if you experience sudden severe flank pain, anuria, or high fever with rigors.
  • Individuals with active bleeding disorders or severe anemia must be assessed by a physician before blood collection.

If you develop rapid deterioration in kidney function, contact emergency services or visit the nearest ER immediately.

Patient FAQ & Clinical Guidance

1. What is the UMOD Gene NGS Test used for?

A: The UMOD NGS test detects mutations causing glomerulocystic kidney disease with hyperuricemia and isosthenuria, enabling precise diagnosis and family cascade screening. It is specifically designed for patients presenting with cystic kidney changes, elevated serum uric acid, and impaired urine concentrating ability.

2. How is the sample collected and what is the turnaround time?

A: A routine peripheral blood draw is collected at your home by a DHA-licensed phlebotomist through our VIP Mobile Phlebotomy service (available 8 AM to 11 PM daily). Results are issued within 3–4 weeks from sample receipt.

3. Is this test covered by health insurance in the UAE?

A: We offer instant direct billing verification; coverage depends on your policy’s genetic testing clause and medical necessity. Send your insurance card image via WhatsApp to +971 54 548 8731 for immediate verification.

4. Can family members also be tested?

A: Yes, cascade testing for first-degree relatives is clinically recommended once a pathogenic UMOD variant is identified in the index patient. Genetic counselling is provided before and after testing for all family members.

UAE Regulatory & Data Privacy Adherence

UAE Regulatory Compliance:

This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic counselling and clinical safety protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Genetic data handling is performed within a secure, ISO 9001:2015–accredited environment under DHA oversight.

Clinical & Logistical Metadata

Test Name UMOD Gene Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria Genetic Test (NGS & Confirmatory Sanger)
Price (AED) 2,800 AED
Turnaround Time 3–4 weeks
Sample Type / Matrix Peripheral whole blood (3–5 mL in EDTA tube), or extracted DNA (2 µg minimum)
Methodology Used Next‑Generation Sequencing (NGS) with confirmatory Sanger sequencing
ICD-10-CM Code Q61.8, E79.0
LOINC Code 92853-9
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians